Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up

nork Bravo, Francisco, Macpherson, Jamie A., Slack, Emma, Patuto, Nicolas, Cahenzli, Julia, McCoy, Kathy D., Macpherson, Andrew J., Juillerat, Pascal
Argitaratua izan da Clin Transl Gastroenterol (2021)